Our previous work has suggested the presence of an insulin resistance in the adult offspring of streptozotocindiabetic pregnant rats. In this study we used the euglycaemic hyperinsulinaemic clamp technique with an isotope-dilution method to define and quantify this postulated insulin resistance in adult offspring of streptozotocin-diabetic rats. Under basal conditions, these rats had a lower body weight than control rats, but their glucose and insulin concentrations were normal. During the hyperinsulinaemic clamp, the steady-state glucose infusion rate was significantly lower in the offspring of streptozotocin-diabetic rats than in both ageand weight-matched controls, indicating insulin resistance. Basal peripheral tissue glucose utilization was normal in the offspring of streptozotocin-diabetic rats, but the dose-response curve was shifted to the right: insulin concentrations causing half-maximal stimulation of glucose utilization were increased by about 60% in the offspring of diabetic rats; the maximal stimulation of glucose utilization, however, was unaltered. Basal hepatic glucose production was normal, but again, half-maximal suppression of glucose production occurred at insulin concentrations 50% higher than in controt rats; in addition, the maximal suppression of glucose production was significantly decreased, even at insulin concentrations of 5700 btU/ml. These data are evidence for an insulin resistance in the adult offspring of streptozotocin-diabetic rats, characterized by: (1) a decreased insulin sensitivity by peripheral glucose-utilizing tissues, and, (2) a decreased sensitivity and responsiveness of the liver.
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Metabolic changes in the pregnant streptozotocindiabetic rat have been shown to affect fetal development and fetal glucose homeostasis [1, 21. A severe hyperglycaemia ( > 20 mmol/1) in the maternal rat results in hyperglycaemia and hypoinsulinaemia of their fetuses. On histology and electronmicroscopy, we found evidence of islet hypertrophy, Beta-cell hyperplasia and Beta-cell degranulation in these fetuses: a 'Beta-cell exhaustion phenomenon' is probably the cause of decreased insulin levels in fetal serum [1, 2] . Malnutrition of the newborn rats by their mothers, causes frequent postnatal death and subnormal glucose and insulin levels in the survivors until weaning [1, 3] . Body weight in the offspring of severely hyperglycaemic rats is significantly lower than normal from day 20 of gestation and it remains significantly lower during postnatal life: during the lactation period and after weaning [1] [2] [3] . The adult offspring of severely hyperglycaemic pregnant rats (SDF-rats) have a normal pancreas on histology and normal serum glucose and insulin concentrations in basal conditions, but their glucose tolerance is clearly impaired [3, 4] . Data from an in vivo 123I-insulin captation study would suggest an insulin resistance in SDF-rats [5] . In this study, we used the euglycaemic hyperinsulinaemic clamp method [6, 7] to characterize and quantitate the postulated insulin resistance in SDF-rats. With the use of a glucose tracer, we determined the effect of insulin on hepatic glucose production and peripheral glucose utilization, and defined the type of insulin resistance [81.
Material and methods

Animals
The animals were adult offspring of control (non-diabetic) and diabetic Wistar (SDF) rats. Diabetes was experimentally induced by an i. v. injection of streptozotocin (35 mg/kg body weight, kindly donated by Upjohn, Punrs, Belgium) on day one of pregnancy (i. e. the day of copulation plug). Severe hyperglycaemia ( > 20 mmol/1) was confirmed in all rats on day 6 and day 20 of gestation.
Only the offspring of rats giving birth to 8 or more pups were included in the study. After weaning the female offspring were kept for the study. All the animals had free access to water and a standard rat laboratory chow. Experiments were performed at 100-120 days of age in control (CA) and SDF-rats. Because the body weight of SDFrats was significantly lower than that of the control rats, a weightmatched control group (Cw; 60-70 days of age) was inctuded in the study.
Experimental procedures
The experiments were started at 12.30 hours; the animals were fasted for 3 h and were thus in the postabsorptive period. Blood glucose levels were lower in the portal vein than in the carotid artery (4.6 • 0.3 mmol/1 vs 4.9 • 0.1 mmol/1 in Ca-rats and 4.4 • 0.1 mmol/l vs 4.7 • 0.2 mmol/1 in SDF-rats; p < 0.01), indicating that the intestine was not adding glucose to the portal circulation.
Rats were anaesthetized with pentobarbitone (60 mg/kg, i.p.), the right carotid artery was catheterized for blood sampling and a tracheotomy was performed. Body temperature was continuously recorded and maintained at 37-38~
A 200 btl blood sample was taken 30 min after the end of the surgery to determine basal glucose and insulin concentrations. The euglycaemic hyperinsulinaemic clamp was started as previously described [7] , using different doses of insulin (3,10, 50 mU. kg-5. rain 1 porcine monocomponent insulin, Novo Industri, Bagsvaerd, Denmark). A primed (0.3 ml) continuous (20 gl/min) infusion of both insulin and D-[3-3H]-glucose (40 gCi, Amersham Laboratories, Buckinghamshire, UK) was given through the right saphenous vein. A variable glucose infusion (10, 20 or 30% solution) was administered through the same saphenous vein 1 min after starting the insulin infusion. Blood glucose levels were measured every 5 min (Yellow Spring glucose analyser 23 A, Yellow Spring, Ohio, USA) and the glucoseinfusion rate was adjusted accordingly to maintain euglycaemia. Steady state was usually reached after 40 min and was maintained during 20 min. Three 200 ~tl blood samples were collected, at 5 to 10 min intervals, for triplicate determination of glucose and insulin concentrations and glucose specific activity. Non-esterified fatty acids (NEFA) and glucagon were determined on the final blood sample.
Endogenous glucose production was determined with an isotope dilution method [9] using D-[3JH]-glucose as a tracer because tritium in position three of the glucose molecule is lost to water in the glycolytic pathway and cannot be reincorporated into glucose [10] . D-[3-3H]-glucose is thus considered to be an irreversible tracer. In the basal state, glucose turnover rate was determined by a primed 
Analytical techniques
Part of each blood sample was deproteinized with Ba(OH)z-ZnSO4 and centrifuged. An aliquot of the supernatant was used for determination of blood glucose concentration according to the D-glucoseoxidase D-peroxidase procedure (GOD-PAP, Boehringer Mannheim, FRO). Another aliquot was evaporated to dryness at 60~ to remove 3H20; the dry residue was dissolved in 200 B1 aq. dist. and counted in a liquid scintillation counter (Packard Co., Canberra, Australia).
Blood samples for determination of insulin, glucagon and NEFA concentration were centrifuged and the plasma was frozen at -20~ Insulin concentrations were measured by radioimmunoassay using a rat and porcine insulin standard (Novo Industri), NEFA were determined using an enzymatic method (enzyme kit, Boehringer Mannheim, FRG) and glucagon by radioimmunoassay (glucagon kit, Medgenix, Fleurus, Belgium).
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Calculations and statistical analysis
In the basal state and during the clamp studies, glucose appearance rate (Ra) equals glucose disappearance rate (Rd) at dynamic equilibrium. Both rates were calculated with the isotope dilution equation: Ra = Rd = F/SA, where F is the tracer infusion rate (dpm/min) and SA the blood glucose specific activity (dpm/mg) under steady state conditions [7] . In the basal state Ra equals hepatic glucose output and Rd equals glucose utilization. During the euglycaemic hyperinsulinaemic clamp, Ra represents the sum of endogenous glucose production and exogenous glucose infusion rate and Rd represents the rate of glucose utilization. The rate of endogenous glucose production was obtained by subtracting the amount of exogenous glucose infused from the isotopically determined Rd, which equaIs Ra at dynamic equilibrium.
Values are given as means • SEM. A univariate frequency distribution test was performed on all data. Analysis of variance determined whether the three groups of animals differed significantly. If analysis of variance indicated that the three groups were different, t-tests were performed to assess the significance of the difference between two specific group means.
Results
All pregnant rats were severely hyperglycaemic and hypoinsulinaemic (Table 1 ). The adult offspring of these rats had a decreased body weight, but their non-fasting glucose and insulin levels were within the normal range (Table 2) . 
Values are means• Number parentheses. " p < 0.01, b p < 0.0001, VS controls of animals is given within 
Clamp studies
During the clamps, blood glucose concentrations were maintained at 98% of the basal euglycaemic level, with a standard deviation of 6%. The coefficient of variation of blood glucose concentrations during the clamp period was 4.25 _4-0.17%. To determine the sensitivity of total-body glucose metabolism to insulin, steady state glucose infusion rates required to maintain euglycaemia, were plotted semilogarithmically vs the corresponding steady state plasma insulin concentrations. The glucose infusion rate was significantly lower in SDF-rats than in Ca-rats (p < 0.001, p < 0.02 and p < 0.01 at insulin infusion rates of 3, 10 and 50 mU. kg-1. min-1, respectively) and in Cw-rats (p < 0.01 at insulin infusion rates of 3, 10 and 50 mU. kg 1 min-1) (Fig. 1) . The dose-response curve was clearly shifted to the right in SDF-rats (Fig. 1) .
Dose-response characteristics for the effect of insulin on glucose utilization and glucose production
Basal rates of glucose utilization were not significantly different between the different groups (Fig. 2) . In SDF-rats, the dose-response curve was shifted to the right: insulin concentration at half-maximal stimulation of glucose utilization was increased from about 120 BU/ml to 200 gU/ml. Maximal stimulation of glucose utilization was not altered in SDF-rats. Glucose utilization increased from a basal rate of 1.97+0.10mg/min, 2.18+0.11rag/rain, and 1.95 _+ 0.10 mg/min to a maximum of 4.89 + 0.07 mg/min, 4.86_+ 0.14 mg/min and 4.90 • rag/rain at plasma insulin concentrations of 3870+320 btU/ml, 3530+ 600 btU/ml and 5730 + 760 btU/ml in respectively CA-, Cw-, and SDF-rats ( Fig. 2 and Table 3 ). The basal rate of glucose production was similar in the three groups (Fig. 3) . The close-response curve was also shifted to the right in SDF-rats: insulin concentrations at half-maximal suppression of glucose production were increased by about 70% (from 110 btU/ml to 180 gU/ml). In addition, the maximal suppression of endogenous glucose production was significantly decreased in SDF-rats (0.84 + 0.05 mg/min) than in CA-rats (0.16 + 0.04 mg/min; p < 0.001) and in Cw-rats (0.07 + 0.08 mg/min;p < 0.001).
Basal plasma glucagon concentrations (Table 3) were not significantly different in SDF-rats and in CA-and Cwrats. Hyperinsulinaemia decreased plasma glucagon concentrations to the same extent in the three groups of animals: after an insulin infusion rate of 50 mU. kg-1 rain-1 41-+5 5731-+763" 4.9_+0.1 4.7-+0.1 56+ 9 0.17-+0.02 9 BPI = basal plasma insulin; SSPI = steady state plasma insulin; BBG = basalblood glucose; SSBG = steady state blood glucose; NEFA = steady state plasma non-esterified fatty acids; Glucagon = steady state plasma glucagon. Values are means -+ SEM. " p < 0.05, vs age-matched controls; b p < 0.05, VS weight-matched controls the percentage decrease from basal values was 42%, 46% and 45% in respectively CA-, Cw-and SDF-rats.
NEFA levels, which were significantly lower in the basal state in SDF-rats compared to CA-and Cw-rats (p < 0.01, respectivelyp < 0.05), decreased less during the different clamps in SDF-rats and became similar to those of the control rats (Table 3) .
Discussion
An insulin resistance was suggested by data showing that SDF-rats, during an i.v. glucose infusion, maintained glucose levels within the control range in the presence of increased insulin levels [4] . Moreover, in vivo 123I-insulin captation studies in these rats demonstrated an elevated renal clearance of insulin, which also suggests a decreased uptake of insulin by peripheral tissues [5] . In the same study, we found that islets of Langerhans were more sensitive to glucose in vitro in SDF-rats than in control rats [5] ; it was then postulated that this hypersecretion of insulin was the consequence of an insulin resistance.
We confirmed that SDF-rats, at 100 days of age, had a lower body weight than control rats, and that they maintained normal glucose and insulin levels in basal conditions [3, 4] . Furthermore, we found a normal basal glucose utilization by peripheral tissues and a normal basal glucose production by the liver in SDF-rats. This finding is compatible with our previous data showing that these adult offspring appear to have recovered quite well from the influences of the abnormal perinatal milieu, at least under basal conditions [3] .
The present results indicate that, using the definitions of Kahn [8] , the peripheral tissues of SDF-rats are less sensitive (decreased half-maximal effect) to insulin, thus confirming our previous results of 123I-insulin captation experiments [5] . On a weight basis, skeletal muscle is the most important glucose-utilizing tissue [11] . In man, it has been demonstrated that skeletal muscles are primarily responsible for the disposal of an intravenous glucose toad in an euglycaemic clamp [12] .
It is most likely that also in SDF-rats skeletal muscle is primarily involved in the peripheral insulin resistance (work in progress). Since all the rats were in the postabsorptive state, the glucose production rate in these studies equals the actual hepatic glucose production rate. The results indicate that, in SDF-rats, the liver is less sensitive (decreased half-maximal effect) and also less responsive (decreased maximal effect) to insulin.
By including weight-matched control rats, we demonstrated that the 17% decrease of body weight in SDF-rats compared to controls is not responsible for the observed effects on glucose utilization and glucose production.
The exact cause of this hepatic and peripheral insulin resistance is unknown at present. Insulin action on target tissues might be altered by a decreased receptor number and/or affinity, or by a post-receptor defect [13, 14] . Changes in the levels of counterregulatory hormones could also be involved, e. g. glucagon stimulates insulin-inhibited hepatic glucose production [14] . In the basal state and during hyperinsulinaemia glucagon levels are not significantly different in SDF-rats and control rats. This suggests that glucagon is probably not involved in the hepatic insulin resistance observed in SDF-rats. Elevated NEFA concentrations are known to reduce insulin-stimulated glucose disposal, especially in muscles [15] . Although NEFA levels are lower in basal conditions in SDF-rats, hyperinsulinaemia decreased plasma NEFA to a lesser extent in SDF-rats than in CA-and Cw-rats. However, plasma NEFA concentrations do not reach significantly higher levels during extreme hyperinsulinaemia in SDFrats. This suggests that NEFA do not inhibit glucose utilization in SDF-rats.
Further studies should also concentrate on the developmental origin of these changes. The insulin resistance could well be the result of the significant metabolic changes in the diabetic intra-uterine milieu. The last days of fetal life are a critical period for the maturation of the insulin receptor and the post -receptor events in the rat [16, 17] . Hypoinsulinaemia, as found in fetuses of severely diabetic rats [1, 2, 18] might affect the receptor ontogenesis: the specific binding of insulin to liver and lung membranes of fetuses of severely diabetic rats was, indeed, found to be decreased [19] . The postnatal milieu also might be involved. Due to nutritional deficiency in the lactation period, the body weight, glucose levels and therefore also insulin levels are below normal [1, 3] . These hypoinsulinaemic levels might also affect the sites of insulin action in the neonate.
Streptozotocin, given to the maternal rat, in early pregnancy is almost certainly not the cause of these changes, because streptozotocin has a very short half-life [20] . Secondly, similar metabolic changes have been reported in fetuses of rats, made hyperglycaemic by a glucose infusion [21, 22] and in the spontaneously diabetic BB rat [18] . Genetic transmission of the defect is also excluded because the offspring of streptozotocin-diabetic fathers do not show changes in glucose homeostasis [23] .
Although a hyperglycaemia of such severity is rarely found in humans, these data suggest that poorly controlled diabetes during pregnancy can affect the glucose-insulin homeostasis in the next generation. Studies in Pima Indians have already shown that, in addition to a genetic transmission of diabetes, the diabetic intra-uterine milieu increases the incidence of an impaired glucose tolerance in children of gestational diabetic mothers [24] .
In conclusion, the present study gives evidence for an insulin resistance in the adult offspring of severely diabetic pregnant rats, characterized by: (1) a decreased insulin sensitivity at the peripheral tissues, and (2) a decreased insulin sensitivity and responsiveness of the liver.
